Update on antibody–drug conjugates: where are we now, & where are we going?

Published: 18 April 2022
Fernanda Arnaldez

“Antibodydrug conjugates are an expanding and promising market segment, as they offer a canvas for innovation almost in any single aspect of their design and development.”

Read now